Core Members of the ASC (L-R): Mark Daly, MD, PhD (Broad Institute of MIT and Harvard); Joseph Buxbaum, PhD (Seaver Autism Center, Icahn School of Medicine at Mount Sinai); Jessica Brownfeld (Seaver Autism Center, Icahn School of Medicine at Mount Sinai); Catalina Betancur, MD, PhD (Univ. Pierre et Marie Curie); Bernie Devlin, PhD (Univ. of Pittsburgh Medical Center); Jeffrey Barrett, PhD (Wellcome Trust Sanger Institute); Edwin Cook, Jr., MD (Univ. of Illinois at Chicago); Silvia De Rubeis, PhD (Seaver Autism Center, Icahn School of Medicine at Mount Sinai); Kathryn Roeder, PhD (Carnegie Mellon Univ.); Michael Zwick, PhD (Emory Univ.); David Cutler, PhD (Emory Univ.); Alison Singer (Autism Science Foundation).
Leaders of the Autism Sequencing Consortium (ASC), an international autism genetics collaboration led by Joseph Buxbaum, PhD, Director of the Seaver Autism Center, met recently in New York City to discuss new studies and advances in the field. To date, the ASC has sequenced 20,000 exomes, and in a recent study published in Nature, identified new autism risk genes. To learn more about the ASC, visit www.autismsequencingconsortium.org.